INTS vs LDOS
Intensity Therapeutics, Inc. Common stock (INTS) versus Leidos Holdings Inc (LDOS) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Leidos Holdings Inc (LDOS) is a information technology services company listed on US.
INTS does not have a complete income-statement cache yet.
Latest reported LDOS revenue for 2025-01-03 was $16.66B. Net income was $1.25B. Revenue was up 7.9% from 2023-12-29 to 2025-01-03. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
INTS currently screens at market cap $7.7M. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
Not investment advice. Open the INTS and LDOS stock pages for the full models.
Not investment advice.